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Background
The 2010 WHO/ICO (Institut Catala d’Oncologia) sum-
mary report states that Malaysia has a population of 8.7
million women aged 15 years and above who are at risk of
developing cervical cancer. Annually, 2126 women are
diagnosed with cervical cancer and 631 die from the dis-
ease. The introduction of HPV vaccine in Malaysia has sig-
nificantly encouraged the introduction of molecular era
which could potentially improve the future of cervical
cancer screening program. This article aimed at reviewing
the proposed methods published from different perspec-
tives in improving the screening and preventive practices
of cervical cancer in Malaysia.
Materials and methods
Published articles and reports from year 2000 onwards
were retrieved from electronic and government databases.
Selected studies include randomized controlled trials
(RCTs), non-randomized controlled trials (CCTs), cross
sectional studies and cost-effectiveness studies. Selected
interventions were accepted models for improving cervical
cancer screening program. Selected outcomes had at least
one of following: reduced morbidity/mortality of cervical
cancer, increased detection of precancerous/cancer lesions,
increased coverage of screening, increased awareness and/
or knowledge and/or barriers to cervical cancer, HPV and
vaccination. Search terms included cervical cancer, screen-
ing, HPV, vaccine, Malaysia, diagnosis, pathology, pap
smear, HPV DNA test and early detection. Articles were
reviewed by two reviewers, for research design and for
grading internal validity of study. The accepted articles
were then reviewed for quality of evidence and external
validity.
Results
In the twenty-eight studies reviewed, among the chal-
lenges of cervical cancer screening (most frequently
mentioned) include cost-effectiveness of vaccine, aware-
ness and knowledge of patients’ on pap smear, human
papillomavirus infection and cervical cancer. Eight of
these studies were small observations on the prevalence
of human papillomavirus in smears taken using new
technologies like HPV DNA test and liquid based cytol-
ogy. Although there was recommendation to introduce
these technologies into the screening program, evidence
of cost-effectiveness was unavailable.
Conclusions
Choosing the most practical and cost-effective approach
for the Malaysian setting is definitely a challenge.
Evidence-based approach should be used by researchers
and practitioners from various disciplines to make this a
success.
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